1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsInnovative Treatments in Disorders of Consciousness (ITDC) Grant is sponsored by Neurocritical Care Society. Supports transformative research aimed at improving outcomes for patients with disorders of consciousness, including coma and vegetative states, through pilot studies and collaborative initiatives.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Innovative Treatments in Disorders of Consciousness (ITDC) Grant About NCS Partner With NCS Research Grants ITDC Grant Innovative Treatments in Disorders of Consciousness (ITDC) Grant Innovative Treatments in Disorders of Consciousness (ITDC) Grant Program The Curing Coma® Campaign, in collaboration with Spaulding Rehabilitation and through the Rehabilitation Outcomes Center at Spaulding (ROCS), invites applications for the Innovative Treatments in Disorders of Consciousness (ITDC) Grant Program .
This funding opportunity is designed to spark bold, high-impact research that advances the diagnosis, understanding and treatment of disorders of consciousness (DoC), including coma, vegetative state and minimally conscious state.
Generate pilot data for future large-scale studies Build infrastructure to support multicenter clinical trials Evaluate biologically plausible, innovative treatments View the Request for Proposals Disorders of consciousness affect hundreds of thousands of individuals in the United States, yet the field faces critical challenges, including high rates of misdiagnosis (~40%), limited tools to accurately detect consciousness and few effective treatment options.
This program seeks to address these gaps by accelerating research that can transform care and outcomes.
Applicants are encouraged to propose innovative work in, but not limited to, the following areas: Clinical Trial Infrastructure: Development of multicenter networks or model systems Neurobiological Mechanisms: Connectomics and circuit mapping Patient Classification: Phenotyping and endotyping Long-Term Outcomes: Recovery trajectories and modeling Biomarkers: Diagnostic, prognostic, and treatment-response validation Prognostication: Machine learning and large dataset modeling Therapeutic Innovation: Novel or repurposed drugs and devices (e.g., DBS, TMS, VNS) Funding & Project Details Award Amount: Up to $200,000 per year (max $400,000 total) Project Duration: Up to 2 years Number of Awards: Approximately 2 Indirect Costs: Up to 20% included Projects should include a clear path to future external funding.
U.S.-based nonprofit organizations, including academic institutions Projects must include at least one Mass General Brigham (MGB) collaborator Interprofessional and multi-institutional teams Inclusion of Spaulding Rehabilitation collaborators Important: Projects must...
Focus on prospective research (no retrospective or meta-analyses) Include patient and stakeholder engagement, incorporating individuals with lived experience Step 1: Letter of Intent (LOI) Submit a brief LOI including: LOIs must be submitted through the online portal once the LOI period opens on May 18.
Applicants are encouraged to develop proposals that: Foster collaboration across institutions and disciplines Engage patients, families, and caregivers as partners Advance scalable solutions for multicenter trials and real-world impact Step 2: Full Proposal (by invitation only) Selected applicants will be invited to submit a full application.
LOI Deadline: June 14, 2026 LOI Notification: August 9, 2026 Full Application Deadline: October 18, 2026 Awards Announced: Early January 2027 Applications will be evaluated based on: Significance: Importance and potential to address critical gaps Innovation: Novelty of concepts, methods, or applications Approach: Scientific rigor, feasibility, and likelihood of success Overall Impact: Potential to meaningfully advance the field Please contact Shonali Gaudino and/or (617) 952-6509.
According to the current listing, eligibility includes: Researchers and clinicians in the field of neurocritical care. Confirm the full requirements in the official notice before applying.
Applications for Innovative Treatments in Disorders of Consciousness (ITDC) Grant are due October 18, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Innovative Treatments in Disorders of Consciousness (ITDC) Grant is funded by Neurocritical Care Society. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
HCU Global Grants Program is sponsored by HCU Network America. HCU Network America provides research grants to support novel proposals for the treatment and prevention of clinical manifestations for Classical Homocystinuria and/or Cobalamin G, a Methionine Synthase deficiency. These grants are intended to support innovative seed or pilot projects to produce preliminary data that would facilitate more substantial funding from federal agencies, foundations, or corporations. An Expression of Interest (EOI) was due May 31, 2026, with full applications due August 31, 2026, and funding decisions by October 31, 2026.
NIA Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The NIA SBIR/STTR programs support small businesses in developing technologies for aging-related health issues, including AI-driven drug discovery tools and assistive technologies for older adults aging in place. These programs aim to help small businesses develop effective treatments and interventions for healthy aging.
The Rural Health Care Program's Third Further Notice hit the Federal Register on August 31, 2026. It proposes killing cost studies, publishing an eligible services list, setting application processing deadlines, and eliminating the Healthcare Connect Fund annual report. What it conspicuously does not propose is any change to the $744.2 million cap that the whole proceeding says is under strain.
Read articleOn August 7, 2026, Judge Mary S. McElroy vacated HUD's FY2026 Continuum of Care NOFO in full, finding the agency violated the Administrative Procedure Act by skipping notice-and-comment before setting aside roughly $1.3 billion — nearly a third of CoC funding — for new projects. HUD has appealed and been denied an emergency stay. Here is what the ruling actually does to renewals, what Congress already guaranteed, and what CoC leads and subrecipients should be doing during the pause.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read article